Net Income (Loss) per Share (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

Basic and diluted net income (loss) per share attributable to common stockholders was calculated as follows:


	Year Ended December 31,
	2022		2021		2020

Basic net income (loss) per share:
Numerator:
Net income (loss)	$	(63,586)	$	(78,485)	$	59,337
Denominator:
Weighted average commons shares outstanding—basic	55,761,386		44,243,317		35,545,121
Net income (loss) per share—basic	$	(1.14)	$	(1.77)	$	1.67

Diluted net income (loss) per share:
Numerator:
Net income (loss) - basic	$	(63,586)	$	(78,485)	$	59,337
Interest expense on convertible note payable	—		—		395
Net income (loss) - diluted	$	(63,586)	$	(78,485)	$	59,732
Denominator:
Weighted average commons shares outstanding—basic	55,761,386		44,243,317		35,545,121
Shares issuable upon conversion of convertible notes, as if converted	—		—		1,282,052
Dilutive effect of restricted stock units	—		—		557,402
Dilutive effect of common stock equivalents	—		—		757,218
Weighted average commons shares outstanding—diluted	55,761,386		44,243,317		38,141,793
Net income (loss) per share—diluted	$	(1.14)	$	(1.77)	$	1.57

Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss per Share Attributable to Common Stockholders

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated above because including them would have had an anti-dilutive effect:


	Year Ended December 31,
	2022	2021
Stock Options to purchase common stock - 2018 Plan	8,233,330	7,057,258
Stock Options to purchase common stock - Inducement Plan	210,400	—
Shares to be issued under the ESPP	1,405,755	1,084,476
RSUs issued and expected to vest	385,980	—
Shares available from conversion of note payable	2,506,306	832,677